Order Total (1 Item Items):
Shipping Destination:
Dinkel Rolf (36 results)
Skip to main search results
Search filters
Product Type
- All Product Types
- Books (36)
- Magazines & Periodicals (No further results match this refinement)
- Comics (No further results match this refinement)
- Sheet Music (No further results match this refinement)
- Art, Prints & Posters (No further results match this refinement)
- Photographs (No further results match this refinement)
- Maps (No further results match this refinement)
- Manuscripts & Paper Collectibles (No further results match this refinement)
Condition Learn more
- New (23)
- As New, Fine or Near Fine (6)
- Very Good or Good (4)
- Fair or Poor (No further results match this refinement)
- As Described (3)
Binding
Collectible Attributes
- First Edition (2)
- Signed (No further results match this refinement)
- Dust Jacket (2)
- Seller-Supplied Images (15)
- Not Print on Demand (24)
Language (3)
Free Shipping
- Free Shipping to U.S.A. (No further results match this refinement)
Seller Location
Seller Rating
-
Improving Drug Safety, A Joint Responsibility (Lecture Notes in Physics)
Language: English
Published by Springer-Verlag GmbH, 1991
ISBN 10: 3540535055 ISBN 13: 9783540535058
Gebundene Ausgabe. Condition: Sehr gut. 338 Seiten ex library book aus einer Unternehmensbibliothek Sprache: Englisch Gewicht in Gramm: 550.
-
Improving Drug Safety, A Joint Responsibility (Lecture Notes in Physics)
Language: English
Published by Springer-Verlag GmbH, 1991
ISBN 10: 3540535055 ISBN 13: 9783540535058
Gebundene Ausgabe. Condition: Sehr gut. 338 Seiten ex LIbrary 'Book aus einer wissenschaftlichen Bibliothek Sprache: Englisch Gewicht in Gramm: 550.
-
Cloth. Condition: Fine. No Jacket. First Edition. This is a fine, unmarked, hardcover first edition copy, blue cloth binding, no DJ.
-
Internationale Markt- und Preisvergleiche im Pharmabereich. Untersuchung der Prognos AG, Abt. Unternehmensberatung.
Language: German
Published by Basel, Prognos AG., 1976
Seller: Antiquariat Thomas Haker GmbH & Co. KG, Berlin, Germany
Association Member: GIAQ
Seller rating 5 out of 5 stars
Paperback. Condition: Gut. 172, 63 S., m. Tab., Guter Zustand. Bibliotheksexemplar mit Stempeln und Signatur auf Einband. Sonst Seiten sauber. Papier / Einband alterungsbedingt am Rand leicht vergilbt. Sprache: Deutsch Gewicht in Gramm: 590.
-
The Perception and Management of Drug Safety Risks (Health Systems Research)
Language: English
Published by Springer-Verlag GmbH, 1989
ISBN 10: 3540505342 ISBN 13: 9783540505341
Gebundene Ausgabe. Condition: Sehr gut. 216 Seiten ex LIbrary 'Book aus einer wissenschaftlichen Bibliothek Sprache: Englisch Gewicht in Gramm: 550.
-
Improving Drug-Safety - A Joint Responsibility
Seller: Webbooks, Wigtown, Wigtown, United Kingdom
Association Member: PBFA
Seller rating 5 out of 5 stars
First Edition
Hard Cover. Condition: Very Good. No Jacket. First Edition. Lightly worn copy.
-
The Perception and Management of Drug Safety Risks (Health Systems Research)
Language: English
Published by Springer 16.01.1989., 1989
ISBN 10: 3540505342 ISBN 13: 9783540505341
Condition: Sehr gut. Auflage: 1. 240 Seiten Sehr gutes Exemplar 55 9783540505341 Sprache: Englisch Gewicht in Gramm: 626 0,0 x 0,0 x 0,0 cm, Gebundene Ausgabe.
-
Condition: New. pp. xxi + 338 1st Edition.
-
Condition: New. pp. xxi + 338 35 Figures.
-
Condition: New. pp. xxi + 338.
-
Kosten-Effektivitäts-Analyse der Zytostatikatherapie von akuter Leukämie im Kindesalter : Unters. d. Prognos-AG, Basel, Köln ; Zsfassung / Rolf Dinkel ; Thomas Schulze-Röbbecke / Pharma-Dialog ; 73
Published by Frankfurt [Main] : Bundesverb. d. Pharmazeut. Industrie, 1982
Seller: Roland Antiquariat UG haftungsbeschränkt, Weinheim, Germany
Seller rating 5 out of 5 stars
Softcover. 19 S. ; 20 x 21 cm Guter Zustand. Leseseiten sind sauber und ohne Markierungen. Ausgeschiedenes Bibliotheksexemplar mit entsprechender Kennzeichnung. Buch weist leichte Lager- bzw. Gebrauchsspuren auf. Sonst gutes Exemplar. Sprache: Deutsch Gewicht in Gramm: 1000.
-
The Perception and Management of Drug Safety Risks (Health Systems Research)
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Seller rating 5 out of 5 stars
£ 96.88
£ 11.98 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketCondition: New. In.
-
Paperback. Condition: Brand New. reprint edition. 240 pages. 9.40x6.80x0.60 inches. In Stock.
-
Condition: New. pp. xxiii + 210.
-
The Perception and Management of Drug Safety Risks
Language: English
Published by Springer Berlin Heidelberg, 2011
ISBN 10: 3642742742 ISBN 13: 9783642742743
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - In the past two decades public debate about the risks, benefits, and safety associated with drugs has intensified. Public disputes over risks are brought to court when individuals seek compensation for health problems attributed to a pharmaceutical product. The issue reaches legislatures and regulatory agencies when consumer advocates seek to influence the standards of drug usage. Front-page news tends to focus on accidents or other risk events with drugs. Drug risk and drug safety have become an important political issue. Drug regulat ory agencies have been instituted, and their responsibility has increased. The approval to market a drug is dependent on a set of sophisticated studies executed according to strict protocols and scientifically defined criteria. Drug surveillance activities have gained recognition, and reporting systems to identify drug safety problems have been strengthened. The understanding and management of drug safety is, nonetheless, beset by doubts, disagreements, and disputes. Conflict occurs over the significance of risk, the adequacy of evidence, the methodologies used to evaluate and measure risk, the standards that guide regulation, and the optimal means of communicating risk information to the public.
-
Improving Drug Safety ? A Joint Responsibility (Health Systems Research)
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Seller rating 5 out of 5 stars
£ 137.84
£ 11.98 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketCondition: New. In.
-
Condition: New. pp. xxi + 338.
-
Condition: Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher | In the past two decades public debate about the risks, benefits, and safety associated with drugs has intensified. Public disputes over risks are brought to court when individuals seek compensation for health problems attributed to a pharmaceutical product. The issue reaches legislatures and regulatory agencies when consumer advocates seek to influence the standards of drug usage. Front-page news tends to focus on accidents or other risk events with drugs. Drug risk and drug safety have become an important political issue. Drug regulat ory agencies have been instituted, and their responsibility has increased. The approval to market a drug is dependent on a set of sophisticated studies executed according to strict protocols and scientifically defined criteria. Drug surveillance activities have gained recognition, and reporting systems to identify drug safety problems have been strengthened. The understanding and management of drug safety is, nonetheless, beset by doubts, disagreements, and disputes. Conflict occurs over the significance of risk, the adequacy of evidence, the methodologies used to evaluate and measure risk, the standards that guide regulation, and the optimal means of communicating risk information to the public.
-
Improving Drug Safety ż A Joint Responsibility
Language: English
Published by Springer Berlin Heidelberg, 2011
ISBN 10: 3642647626 ISBN 13: 9783642647628
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - As the focus on pharmaceuticals has broadened from concern for their cost and effectiveness to their real and potential risks and benefits, a critical question has been raised: whose responsibility is it to improve drug safety In April 1990, this question became the theme for a conference at Wolfsberg, Switzerland, near the shores of Lake Constance. Called an 'international dialogue conference' by its organizers, the meeting brought together leaders from the pharmaceutical industry, regulatory authorities, academia, medicine, consumer organizations and the media. Opening addresses were given by representatives of the Council for International Organizations of Medical Sciences (CIOMS), the International Federation of Pharmaceutical Manufacturers Associations (IFPMA), the Swiss International Pharmaceutical Agency, and the RAD-AR Consortium. This book documents the papers presented and discussions held at this conference, which took the topic of risks and benefits of drug therapy one step further to responsibility. It includes a rich menu of issues for those who care about the evaluation of drug therapy, the ethics behind it, the expectations of the patient, and the role of traditional and nontraditional drug safety communica tions. The ideas expressed here come from different parts of the world but relate to common drug safety problems, observations, and scientific assessments; they provide insights into innovative approaches, cautious changes, and desired actions. The papers in this volume are broadly divided into conceptual perspectives (ethics, how the knowledge about drug risks and benefits is generated and appraised, the expectations in drug safety) and operational perspectives (communication, discussion, and action).
-
Paperback. Condition: Brand New. reprint edition. 359 pages. 9.53x0.82x6.69 inches. In Stock.
-
Sozioökonomie der chronischen Herzinsuffizienz : eine Krankheitskostenstudie in der Bundesrepublik Deutschland / Rolf Dinkel ; Karin Büchner ; Jürgen Holtz / Gesundheit und Ökonomie ; Bd. 3
Language: German
Published by Bern ; Frankfurt am Main ; New York ; Paris : Lang, 1989
ISBN 10: 3261041609 ISBN 13: 9783261041609
Seller: Roland Antiquariat UG haftungsbeschränkt, Weinheim, Germany
Seller rating 5 out of 5 stars
Broschiert. 102 S. ; 24 cm Guter Zustand. Leseseiten sind sauber und ohne Markierungen. Ausgeschiedenes Bibliotheksexemplar mit den üblichen Kennzeichnungen. Buch weist leichte Lagerspuren bzw. Gebrauchsspuren auf. Sonst gutes Exemplar. 9783261041609 Sprache: Deutsch Gewicht in Gramm: 200.
-
Kosten-Nutzen-Analyse der Malariaprophylaxe bei Kenyareisenden mit Mefloquin / Rolf Dinkel ; Felix Gutzwiller ; Robert Steffen / Gesundheit und Ökonomie ; Bd. 4
Language: German
Published by Bern ; Frankfurt am Main ; New York ; Paris : Lang, 1990
ISBN 10: 3261043016 ISBN 13: 9783261043016
Seller: Roland Antiquariat UG haftungsbeschränkt, Weinheim, Germany
Seller rating 5 out of 5 stars
Kartoniert. 127 S.; 11 Abb., 29 Tab. Sehr guter Zustand. Leseseiten sind sauber und ohne Markierungen. Ausgeschiedenes Bibliotheksexemplar mit den üblichen Kennzeichnungen. Buch weist leichte Lagerspuren auf. Sonst sehr gutes Exemplar. 9783261043016 Sprache: Deutsch Gewicht in Gramm: 500.
-
Sozio konomie der chronischen Herzinsuffizienz: Eine Krankheitskostenstudie in der Bundesrepublik Deutschland (Gesundheit und konomie) (German Edition)
Language: German
Published by Peter Lang International Academic Publishers, 1989
ISBN 10: 3261041609 ISBN 13: 9783261041609
paperback. Condition: Good. Good. Dust Jacket NOT present. CD WILL BE MISSING. . SHIPS FROM MULTIPLE LOCATIONS. book.
-
Kosten/Nutzen-Analyse der Malariaprophylaxe bei Kenyareisenden mit Mefloquin (Gesundheit und konomie) (German Edition)
Language: German
Published by Peter Lang International Academic Publishers, 1990
ISBN 10: 3261043016 ISBN 13: 9783261043016
paperback. Condition: Very Good. Very Good. Dust Jacket may NOT BE INCLUDED.CDs may be missing. SHIPS FROM MULTIPLE LOCATIONS. book.
-
Condition: new. Questo è un articolo print on demand.
-
Condition: new. Questo è un articolo print on demand.
-
The Perception and Management of Drug Safety Risks
Language: English
Published by Springer Berlin Heidelberg Dez 2011, 2011
ISBN 10: 3642742742 ISBN 13: 9783642742743
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Seller rating 5 out of 5 stars
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -In the past two decades public debate about the risks, benefits, and safety associated with drugs has intensified. Public disputes over risks are brought to court when individuals seek compensation for health problems attributed to a pharmaceutical product. The issue reaches legislatures and regulatory agencies when consumer advocates seek to influence the standards of drug usage. Front-page news tends to focus on accidents or other risk events with drugs. Drug risk and drug safety have become an important political issue. Drug regulat ory agencies have been instituted, and their responsibility has increased. The approval to market a drug is dependent on a set of sophisticated studies executed according to strict protocols and scientifically defined criteria. Drug surveillance activities have gained recognition, and reporting systems to identify drug safety problems have been strengthened. The understanding and management of drug safety is, nonetheless, beset by doubts, disagreements, and disputes. Conflict occurs over the significance of risk, the adequacy of evidence, the methodologies used to evaluate and measure risk, the standards that guide regulation, and the optimal means of communicating risk information to the public. 240 pp. Englisch.
-
The Perception and Management of Drug Safety Risks
Language: English
Published by Springer Berlin Heidelberg, 2011
ISBN 10: 3642742742 ISBN 13: 9783642742743
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. In the past two decades public debate about the risks, benefits, and safety associated with drugs has intensified. Public disputes over risks are brought to court when individuals seek compensation for health problems attributed to a pharmaceutical product.
-
The Perception and Management of Drug Safety Risks
Language: English
Published by Springer, Springer Dez 2011, 2011
ISBN 10: 3642742742 ISBN 13: 9783642742743
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germany
Seller rating 5 out of 5 stars
Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -In the past two decades public debate about the risks, benefits, and safety associated with drugs has intensified. Public disputes over risks are brought to court when individuals seek compensation for health problems attributed to a pharmaceutical product. The issue reaches legislatures and regulatory agencies when consumer advocates seek to influence the standards of drug usage. Front-page news tends to focus on accidents or other risk events with drugs. Drug risk and drug safety have become an important political issue. Drug regulat ory agencies have been instituted, and their responsibility has increased. The approval to market a drug is dependent on a set of sophisticated studies executed according to strict protocols and scientifically defined criteria. Drug surveillance activities have gained recognition, and reporting systems to identify drug safety problems have been strengthened. The understanding and management of drug safety is, nonetheless, beset by doubts, disagreements, and disputes. Conflict occurs over the significance of risk, the adequacy of evidence, the methodologies used to evaluate and measure risk, the standards that guide regulation, and the optimal means of communicating risk information to the public.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 240 pp. Englisch.
-
Condition: New. Print on Demand pp. xxiii + 210 29 Figures.
